Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Feb 6 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 5,000 | $29.04 | $145.2K | -0.7% | Open the original filing on SEC.gov |
| Jan 20 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 14,509 | $26.90 | $390.3K | -1.9% | Open the original filing on SEC.gov |
| Jan 20 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 5,491 | $26.37 | $144.8K | -0.7% | Open the original filing on SEC.gov |
| Jan 9 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 50,000 | $29.13 | $1.5M | -6.1% | Open the original filing on SEC.gov |
| Jan 9 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 41,198 | $24.90 | $1M | -4.8% | Open the original filing on SEC.gov |
| Jan 8 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 33,802 | $24.92 | $842.5K | -3.8% | Open the original filing on SEC.gov |
| Jan 8 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 7,500 | $20.13 | $151K | -0.8% | Open the original filing on SEC.gov |
| Dec 19, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 5,000 | $16.84 | $84.2K | -0.5% | Open the original filing on SEC.gov |